Skip to main content
Clinical Trials/NCT03461029
NCT03461029
Completed
N/A

Bispectral Index Monitoring During Anesthesiologist - Directed Sedation in Scheduled Colonoscopies

Hospital Galdakao-Usansolo1 site in 1 country196 target enrollmentJanuary 30, 2016
ConditionsColonoscopy

Overview

Phase
N/A
Intervention
Not specified
Conditions
Colonoscopy
Sponsor
Hospital Galdakao-Usansolo
Enrollment
196
Locations
1
Primary Endpoint
Level of sedation
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The aim of the study is to establish and identify the level of sedation that is performed in the endoscopy rooms of Galdakao Hospital. To do this, the investigators used the BIS monitoring system, which obtains objective values in real time from the anesthesia performed. The monitoring is completed with basic parameters validated by European guidelines (heart rate, blood pressure, oxygen saturation and respiratory rate), capnography and Ramsay sedation scale, widely validated for use outside the operating room. The main work hypothesis was that in at least 10% of the patients BIS values compatible with moderate or deep sedation would be obtained (BIS <65).

Detailed Description

Observational study in patients undergoing scheduled colonoscopy in endoscopy rooms of the Galdakao-Usansolo Hospital. The investigators objectified the level of sedation that was performed in these procedures using Bispectral Index Monitoring, as well as the total dose of medication required and the level of satisfaction obtained after completing the sedation. The incidence of hemodynamic and respiratory complications observed was included, as well as the treatment needed to solve them. A total of 196 patients were needed to obtain statistically significant results. Qualitative variables are expressed in the form of freguencies and percentages and continuous variables in the form of means and stnadard deviations. Comparisions of percentages were made by the Chi square test and the difference of means in the continuous variables by the t test.Stadistical significance will be assumed when p\<0.05. All estadistical analyzes were carried out using SAS V9.4 (SAS Institute, Inc., Carey, NC).

Registry
clinicaltrials.gov
Start Date
January 30, 2016
End Date
February 20, 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hospital Galdakao-Usansolo
Responsible Party
Principal Investigator
Principal Investigator

Iratxe González Mendibil

Principal Investigator

Hospital Galdakao-Usansolo

Eligibility Criteria

Inclusion Criteria

  • Indication of scheduled colonoscopy.
  • Classification of physical status ASA I, II and III.
  • Intermitent or persistent mild asthma.
  • Body Mass Index (BMI) \< 35 kg/m
  • Intact neurological capacity.
  • Acceptance to participate in the study after signing written informed consent.

Exclusion Criteria

  • BMI \> 35 kg/m
  • Allergy to any of the medications using in sedation, or its components.
  • Known mental or neurological disease.
  • Chronic Obstructive Pulmonary Disease (COPD) or Obstructive Sleep Apnea.
  • Chronic opiate users.
  • Refusal to participate in the study.

Outcomes

Primary Outcomes

Level of sedation

Time Frame: 1 year.

Sedation measured by Bispectral Index Monitoring.

Secondary Outcomes

  • Complications related to sedation.(1 year.)
  • Level of satisfaction with the sedation.(1 year.)

Study Sites (1)

Loading locations...

Similar Trials